drug resistance Archives - GO2 for Lung Cancer

An Oncologist’s View: Navigating the Unique Challenges of Transformed Small Cell Lung Cancer

Matthew Reiss MSE PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer, and Jared Weiss MD, Section Chief of Thoracic and Head & Neck Oncology, Professor of Medicine, University of North Carolina at Chapel Hill It is [...]

Small Cell Lung Cancer Transformation: What Is It and How Do We Treat It?

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:45:20-05:00April 28th, 2022|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer People with lung cancer receiving treatment may encounter acquired drug resistance—a reduction in treatment effectiveness over time. Tagrisso (osimertinib) is currently a frontline treatment for people [...]